Item 8.01. Other Events.

On November 1, 2022, 9 Meters Biopharma, Inc. (the "Company") received written notification from Nasdaq Stock Market LLC ("Nasdaq") confirming that the Company's common stock had a closing price of $1.00 or greater for the ten consecutive trading days from October 18, 2022 to October 31, 2022 and that as a result the Company had regained compliance with Nasdaq Listing Rule 5550(a)(2) (the "Bid Price Rule") and that the matter is now closed.

As previously reported, on February 8, 2022, Nasdaq notified the Company that for the last 30 consecutive business days, the bid price for the Company's common stock had closed below the minimum $1.00 per share requirement for continued inclusion on the Nasdaq Capital Market pursuant to the Bid Price Rule. On August 9, 2022, the Company received formal notice that Nasdaq had granted the Company's request for an extension through February 6, 2023 to evidence compliance with the Bid Price Rule.

--------------------------------------------------------------------------------

© Edgar Online, source Glimpses